Search Results 811-820 of 16379 for monoclonal antibody

1. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   ... antibody, avelumab, in selected advanced solid tumors. ... Known prior severe hypersensitivity reaction to monoclonal antibodies (grade ≥ 3 by NCI CTCAE v4.

2. Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

   Pertuzumab, an anti-HER2 humanized monoclonal antibody ... In this respect, anti-ErbB2 monoclonal antibody 4D5 specifically inhibits the growth of tumor cells ...

3. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T) - Mayo Clinic

   Any patients who received a desensitization therapy including any monoclonal antibodies, plasmapheresis, and/or splenectomy; Inability to understand and sign ...

4. Validation of Dried Blood Spots for Detection of Antibodies to Treponema Pallidum - Mayo Clinic

   About this study. The purpose of this research is to validate new testing methods for diagnosing patients with Treponema pallidum (syphilis).

5. Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors - Mayo Clinic

   ... monoclonal antibodies; 1 week for hormonal anti-cancer therapy) prior to starting study drug or who have not recovered to grade 1 or better from related ...

6. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors. Print details. Share; Facebook · Twitter.

7. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Other monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, antibody-like drugs, cytokines, cell therapies, or radioimmunoconjugates: 4 weeks.

8. Brain Stereotactic Radiosurgery Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

9. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   ... monoclonal antibodies): 2 weeks. Immune-checkpoint inhibitors (e.g., anti-PD-1, anti-PD-L1, or anti-CTLA-4), monoclonal antibodies, antibody-drug conjugates ...

10. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    Received monoclonal antibodies targeting cytokines (e.g., tumor necrosis factor (TNF) inhibitors, anti-IL-1 [e.g., anakinra, canakinumab], anti-IL-6 [e.g. ...